FDA accepts filing of Zohydro ER for Chronic Pain treatment - 19-Jul-2012
The FDA has accepted for review the new drug application (NDA) for the oral, extended-release hydrocodone therapy ZohydroER from Zogenix Inc., as a treatment for moderate to severe Chronic Pain.The FDA set 1 March 2013 as the Prescription Drug User Fee Act action date – granting a 10-month standard review.
Related News
FDA Advisory Committee rejects Zohydro for Chronic Pain treatment
Zogenix files NDA with FDA for Zohydro Chronic Pain treatment
Lexapro/Cipralex (Forest Labs/Lundbeck) reduces Pain in opiod-dependent patients
FDA approves Nymalize (Arbor Pharmaceuticals) for Sub Arachnoid Haemorrhage
CE Mark granted for Architectt HbA1c test to diagnose Diabetes
Enzastaurin (Eli Lilly) fails Phase III trial for B Cell Lymphoma
FDA approves Ilaris (Novartis) for treatment of Systemic Juvenile Idiopathic Arthritis
Merck Inc files MK 3641 at FDA for treatment of Ragweed Pollen Allergies
Related Pain Management Information
Pain Management Clinical Guidelines
Early management of persistent non-specific low back pain
NICETherapeutic endoscopic division of epidural adhesions
NICEPain Management Clinical Trials
Craniosacral Therapy to Treat Chronic Low Back Pain
Clinicaltrials.gov 24 March 2013Efficacy Study of Cognitive Behavioural Treatment With Support on Communication and Information Technologies for the Management of Chronic Low Back Pain (POETS)
Clinicaltrials.gov 27 February 2013Pain Management Medical Journal Abstracts
The role of circulating sex hormones in menstrual cycle dependent modulation of pain-related brain activation
Pain 04 January 2013The pattern and time course of somatosensory changes in the human UVB sunburn model reveal the presence of peripheral and central sensitization
Pain 04 January 2013Pain Management Medical Apps
Pain Scale
Free
Doctot Pain
£3.99
Related Pain Management Drugs
- PANADOL ACTIFAST
- DISPERSIBLE CO-CODAPRIN TABLETS BP 8/400MG
- DIAMORPHINE HYDROCHLORIDE INJECTION BP 5MG
- NOBLIGAN TABLETS
- ZYDOL SR 50 MG TABLETS
- ZOMIG 5MG NASAL SPRAY
- QUTENZA 179MG CUTANEOUS PATCH
- ACTIQ
- SEVREDOL TABLETS 10MG, 20MG AND 50MG
- ORAMORPH
- DUROGESIC DTRANS 12/25/50/75/100 MCG/HR TRANSDERMAL PATCH
- ZAMADOL 24HR 150 (200/300/400)MG TABLETS
- OXYCONTIN TABLETS
- ZYDOL SR TABS 100MG
- ASPIRIN TABLETS BP 300MG
- ZAMADOL INJECTION
- ZOMIG 2.5MG TABS (MIGRAINE)
- TRAMACET 37.5 MG/325 MG EFFERVESCENT TABLETS
- TYLEX
- FROBEN TABLETS
- DHC CONTINUS PROLONGED RELEASE TABLETS 60MG, 90MG AND 120 MG
- SANOMIGRAN
- MATRIFEN
- ALVEDON SUPPOSITORIES 60, 125, 250 MG
- MXL
- ZOMORPH
- ABSTRAL SUBLINGUAL TABLETS
- MST CONTINUS SUSPENSIONS 20, 30, 60, 100 AND 200 MG
- DISPRIN DIRECT
- PALEXIA 50 MG FILM-COATED TABLETS
- TRAMACET 37.5 MG/ 325 MG FILM-COATED TABLETS
- MORPHINE SULPHATE INJECTION
- ZERIDAME SR PROLONGED RELEASE TABLETS
- XEFO
- PANADOL EXTRA ADVANCE 500 MG/65 MG TABLETS
- PALLADONE SR CAPSULES
- PARACODOL TABLETS
- TORADOL INJECTION
- MAXALT
- ZAMADOL SR CAPSULES 50MG, 100MG, 150MG, 200MG
- NUBAIN
- CODIPAR 15MG/500MG EFFERVESCENT TABLETS
- MEPTID INJECTION
- EFFENTORA 100, 200, 400, 600 AND 800 MICROGRAMS BUCCAL TABLETS
- MEDINOL PAEDIATRIC
- PALFIUM
- CODIPAR CAPLETS 15/500
- MIGRANAL
- MST CONTINUS TABLETS 5 MG, 10 MG, 15 MG, 30 MG, 60 MG, 100 MG, 200 MG
- CO-CODAMOL EFF.
- ZOMIG RAPIMELT 5 MG ORODISPERSIBLE TABLETS
- IMIGRAN RECOVERY
- OXYCONTIN 15 MG, 30 MG, 60 MG, 120MG PROLONGED RELEASE TABLETS
- SOLPADOL
- CLOTAM RAPID
- TILODOL SR 150 MG PROLONGED-RELEASE TABLETS
- MAXITRAM SR
- CODEINE PHOSPHATE TABLETS 15MG
- ACUPAN
- CALPOL INFANT SUGAR FREE COLOUR FREE 120 MG/5 ML ORAL SUSPENSION
- DROMADOL SR
- TILODOL SR 200 MG PROLONGED-RELEASE TABLETS
- FORTRAL
- CODEINE PHOSPHATE TABLETS 30MG
- JUNIOR PARAPAED PARACETAMOL SUSPENSION 120MG/5ML
- CYCLIMORPH 15 INJECTION
- OXYNORM LIQUID 5 MG/5 ML ORAL SOLUTION AND OXYNORM CONCENTRATE 10 MG/ML ORAL SOLUTION
- TILODOL SR 100 MG PROLONGED-RELEASE TABLETS
- OXYNORM 5, 10, 20 MG
- PARAMAX
- DIFLUNISAL (ANALGESIA) (GENERIC)
- ASPAV
- PALLADONE CAPSULES
- NARAMIG (MIGRAINE)
- DOMPERAMOL
- ZAMADOL MELT 50 MG TABLETS
- MORCAP SR
- MORPHINE SULPHATE SUPPOSITORIES
- VEGANIN
- OXYNORM 50 MG/ML, SOLUTION FOR INJECTION OR INFUSION
- ZAMADOL CAPSULES 50 MG
- MEFENAMIC ACID (GENERIC)
- LOPRESOR (MIGRAINE)
- DROMADOL XL
- DEXTROPROPOXYPHENE (GENERIC)
- TRANSTEC TRANSDERMAL PATCH
- OSMANIL 75MCG/HR TRANSDERMAL PATCHES
- PETHIDINE
- ZYDOL SOLUTION FOR INJECTION
- OXYNORM 10 MG/ML SOLUTION FOR INJECTION OR INFUSION
- PENTAZOCINE TABLETS BP 25MG
- ANADIN ULTRA DOUBLE STRENGTH 400MG CAPSULES/ANADIN LIQUIFAST 400MG CAPSULES
- SOLPADEINE MAX SOLUBLE TABLETS
- ALMOGRAN 12.5 MG FILM-COATED TABLET
- MIDRID
- ZYDOL 50 MG CAPSULES
- TRAMAKE
- MIGRIL
- ZYDOL 50 MG SOLUBLE TABLETS
- CAFERGOT
- MIGRALEVE
- FLURBIPROFEN
- DICLOFENAC SODIUM 50MG TABLETS
- DEPODUR (EXTENDED RELEASE MORPHINE SULFATE)
- MORAXEN
- MIGRAMAX
- ELLIMANS UNIVERSAL MUSCLE RUB LOTION
- TEMGESIC
- TRAMADOL
- IMIGRAN RADIS TABLETS (50MG AND 100MG)
- ANADIN IBUPROFEN
- BUTRANS 5, 10 AND 20UG/H TRANSDERMAL PATCH
- RELPAX 20MG AND 40MG FILM-COATED TABLETS
- VERSATIS 5% MEDICATED PLASTER
- DIHYDROCODEINE TABLETS BP 30MG
- REMEDEINE
Advert for Healthcare Professionals only